Translation efficiency of EBNA1 encoded by lymphocryptoviruses influences endogenous presentation of CD8+ T cell epitopes

European Journal of Immunology

Volumn 37, Issue 2, 2007, Pages 328-337

  Tellam, Judy ^a   Rist, Michael ^a   Connolly, Geoff ^a   Webb, Natasha ^a   Fazou, Chrysa ^a   Wang, Fred ^b   Khanna, Rajiv ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Antigen processing; Protein translation; T cells; Viral

Indexed keywords

ALANINE; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ENCODED NUCLEAR ANTIGEN 1; GLYCINE; UNCLASSIFIED DRUG; EBV ENCODED NUCLEAR ANTIGEN 1; EBV-ENCODED NUCLEAR ANTIGEN 1; EPITOPE;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINE; CELL SURFACE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENETIC TRANSFECTION; HERPES VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RNA TRANSLATION; ANIMAL; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS;

ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITOPES, T-LYMPHOCYTE; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HUMANS; IMMUNOBLOTTING; LYMPHOCRYPTOVIRUS; PROTEIN BIOSYNTHESIS; TRANSFECTION;

EID: 33947720540     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636153     Document Type: Article

References (29)

1. Wang, F., Rivailler, P., Rao, P. and Cho, Y., Simian homologues of Epstein-Barr virus. Philos. Trans. R. Soc. Land. B. Biol. Sci. 2001. 356: 489-497.
2. Khanna, R. and Burrows, S. R., Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases. Annu. Rev. Microbiol. 2000. 54: 19-48.
3. Khanna, R., Moss, D. J. and Gandhi, M., Applications of emerging immunotherapeutic strategies for Epstein-Barr virus-associated malignancies. Nat. Clin. Parct. Oncol. 2005. 2: 138-149.
4. Rickinson, A. B. and Moss, D. J., Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Ann. Rev. Immunol. 1997. 15: 405-431.
5. Khanna, R., Burrows, S. R., Kurilla, M. G., Jacob, C. A., Misko, I. S., Sculley, T. B., Kieff, E. and Moss, D. J., Localization of Epstein-Barr virus cytotoxic T-cell epitopes using recombinant vaccinia: implications for vaccine development. J. Exp. Med. 1992. 176: 169-176.
6. Murray, R. J., Kurilla, M. G., Brooks, J. M., Thomas, W. A., Rowe, M., Kieff, E. and Rickinson, A. B., Identification of target antigens for the human cytotoxic T-cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J. Exp. Med. 1992. 176: 157-168.
7. Kieff, E., Epstein-Barr virus and its replication. In Fields, B. N., Knipe, D. M. and Howley, P. M. (Eds.) Fields Virology. Lippincott-Raven Press, Philadelphia 1996, pp 2343-2396.
8. + T lymphocytes. J. Exp. Med. 2004. 199: 459-470.
9. + T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1. J. Exp. Med. 2004. 199: 1421-1431.
10. Lee, S. P., Brooks, J. M., Al Jarrah, H., Thomas, W. A., Haigh, T. A., Taylor, G. S., Hurnme, S. et al., CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1. J. Exp. Med. 2004. 199: 1409-1420.
11. Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald Mullen, P. M., Klein, G., Kurilla, M. G. and Masucci, M. G., Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 1995. 375: 685-688.
12. + T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the FBNA-1 homotogue. J. Virol. 2005. 79: 12681-12691.
13. Blake, N. W., Moghaddam, A., Rao, P., Kaur, A., Glickman, R., Cho, Y. G., Marchini, A. et al., Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1. J. Virol. 1999. 73: 7381-7389.
14. Yin, Y., Manoury, B. and Fahraeus, R., Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science 2003. 301: 1371-1374.
15. Levitskaya, J., Sharipo, A., Leonchiks, A., Ciechanover, A. and Masucci, M. G., Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc. Natl. Acad. Sci. USA 1997 94: 12616-12621.
16. Burrows, S. R., Rodda, S. J., Suhrbier, A., Geysen, H. M. and Moss, D. J., The specificity of recognition of a cytotoxic T lymphocyte epitope. Eur. J. Immunol. 1992. 22: 191-195.
17. Thorley-Lawson, D. A., Epstein-Barr virus: Exploiting the immune system. Nat. Rev. Immunol. 2001. 1: 75-82.
18. Khanna, R., Burrows, S. R., Steigerwald Mullen, P. M., Thomson, S. A., Kurilla, M. G. and Moss, D. J., Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: Implications for viral persistence and tumor surveillance. Virology 1995. 214: 633-637.
19. + T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity 1997 7: 791-802.
20. + T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. J. FXp. Med. 2000. 191: 1649-1660.
21. Holowaty, M. N., Zeghouf, M., Wu, H., Tellam, J., Athanasopoulos, V., Greenblatt, J. and Frappier, L., Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. J. Biol. Chem. 2003. 278: 29987-29994.
22. Jones, R. J., Smith, L. J., Dawson, C. W., Haigh, T., Blake, N. W. and Young, L. S., Epstein-Barr virus nuclear antigen 1 (EBNA1) induced cytotoxicity in epithelial cells is associated with EBNA1 degradation and processing. Virology 2003. 313: 663-676.
23. Frappier, L. and O'Donnell, M., Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein-Barr virus. J. Biel. Chem. 1991. 266: 7819-7826.
24. Alexander, J., Payne, J. A., Murray, R., Frelinger, J. A. and Cresswell, P., Differential transport requirements of HLA and H-2 class I glycoproteins. Immunogenetics 1989. 29: 380-388.
25. Shimizu, Y., Geraghty, D. E., Koller, B. H., Orr, H. T. and DeMars, R., Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc. Natl. Acad. Sci. USA. 1988. 85: 227-231.
26. Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A. and Fusenig, N. E., Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell. Biol. 1988. 106: 761-771.
27. Simmons, N. L., A cultured human renal epithelioid cell line responsive to vasoactive intestinal peptide. Exp. Physiol. 1990. 75: 309-319.
28. + T cell recognition. J. Biol. Chem. 2001. 276: 33353-33360.
29. Yotnda, P., Onishi, H., Heslop, H. E., Shayakhmetov, D., Lieber, A., Brenner, M. and Davis, A., Efficient infection of primitive hematopoietic stem cells by modified adenovirus. Gene Ther. 2001. 8: 930-937.